Melphalan
Showing 1 - 25 of 1,022
Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)
Not yet recruiting
- Acute Myeloid Leukemia
- MCBC regimen
- Bu/Cy regimen
- (no location specified)
Nov 13, 2023
Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)
Completed
- Multiple Myeloma
- Thalidomide+Melphalan +Bortezomib+stem cell transplant
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Dec 16, 2022
Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)
Not yet recruiting
- Multiple Myeloma
- Melphalan and Treosulfan
- Melphalan
- (no location specified)
Dec 5, 2022
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Frankfurt, Hannover, Jena (Delcath Hepatic Delivery System,
Terminated
- Hepatocellular Carcinoma
- Intrahepatic Cholangiocarcinoma
- Delcath Hepatic Delivery System
- Melphalan
-
Frankfurt, Germany
- +2 more
Oct 13, 2022
Uveal Melanoma Trial in Ribeirão Preto (Melphalan Injection, Plaque brachytherapy)
Enrolling by invitation
- Uveal Melanoma
- Melphalan Injection
- Plaque brachytherapy
-
Ribeirão Preto, SP, BrazilHospital das Clinicas da Faculdade de Medicina de Ribeirao Preto
May 29, 2023
Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)
Recruiting
- Lymphoma
- BEAM Protocol
- CEM protocol
-
Cairo, EgyptInternational Medical Center (IMC) Hospital, Cairo, Egypt.
Apr 1, 2023
Multiple Myeloma, Newly Diagnosed Patients Trial in Torino (Melphalan, Lenalidomide, Prednisone)
Active, not recruiting
- Multiple Myeloma
- Newly Diagnosed Patients
- Melphalan
- +2 more
-
Torino, ItalyDivision of Hematology, AOU Città della Salute e della Scienza d
Mar 24, 2022
Multiple Myeloma Trial in Seattle (Allopurinol, Carmustine, Etoposide)
Recruiting
- Multiple Myeloma
- Allopurinol
- +4 more
-
Seattle, WashingtonSwedish Cancer Institute
Jun 21, 2022
Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)
Active, not recruiting
- Multiple Myeloma
- Auto Stem Cell Transplant
-
Hackensack, New JerseyJohn Theurer Cancer Center @ Hackensack University Medical Cente
Dec 23, 2022
Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)
Completed
- Multiple Myeloma
- Uproleselan
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
Lymphoma Trial in New York (rituximab, bendamustine, melphalan)
Active, not recruiting
- Lymphoma
- rituximab
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 10, 2023
Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)
Recruiting
- Hematological Malignancy
- Multiple Myeloma
- Evomela
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022
Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)
Completed
- Multiple Myeloma
- Selinexor
- +4 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022
Amyloidosis; Systemic Trial in Boston (Propylene Glycol-Free Melphalan Hydrochloride)
Terminated
- Amyloidosis; Systemic
- Propylene Glycol-Free Melphalan Hydrochloride
-
Boston, MassachusettsBoston Medical Center
Jul 1, 2022
Multiple Myeloma Trial in Suzhou (Tocilizumab)
Recruiting
- Multiple Myeloma
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
May 3, 2023
Multiple Myeloma Trial in Beijing (melphalan HCl for injection)
Recruiting
- Multiple Myeloma
- melphalan hydrochloride for injection
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 26, 2022
Multiple Myeloma Trial in Washington, Hackensack (Melphalan, Bortezomib)
Active, not recruiting
- Multiple Myeloma
- Melphalan
- Bortezomib
-
Washington, District of Columbia
- +1 more
May 6, 2022
Multiple Myeloma Trial (RP followed by MPR)
Active, not recruiting
- Multiple Myeloma
- RP followed by MPR
- (no location specified)
Mar 24, 2022
Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)
Recruiting
- Lymphoma
- +4 more
- Pharmacokinetics
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 12, 2022
Multiple Myeloma Trial in Cleveland (Evomela, Next Generation Sequencing, Prochlorperazine)
Not yet recruiting
- Multiple Myeloma
- Evomela
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Apr 19, 2022
Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)
Not yet recruiting
- Uveal Melanoma
- Metastatic Cutaneous Melanoma
- Autologous Tumor Infiltrating Lymphocytes
- +2 more
- (no location specified)
Jun 5, 2023
Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT
Not yet recruiting
- Multiple Myeloma
- Dara-VRd intensification, Dara-R maintenance
- +4 more
- (no location specified)
Dec 13, 2022
Multiple Myeloma Trial in Hackensack (Fludarabine monophosphate, melphalan, Bortezomib)
Completed
- Multiple Myeloma
- Fludarabine monophosphate, melphalan, Bortezomib
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Apr 29, 2022
Melanoma, Ocular Trial in Tampa, Durham (Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS))
Available
- Melanoma, Ocular
- Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS)
-
Tampa, Florida
- +1 more
Mar 23, 2022
Leukemia, MDS Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- fludarabine phosphate
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022